NewGenIvf Group (NIVF) director files Form 3 initial ownership report

Rhea-AI Filing Summary

NewGenIvf Group Ltd director files initial ownership report. Director Ching Chan Florianna Ann Chi Wan submitted a Form 3 as an insider of NewGenIvf Group Ltd. The filing reports no insider transactions, exercises, gifts, or restructurings and serves only as an initial statement of beneficial ownership.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ching Chan Florianna Ann Chi Wan

(Last) (First) (Middle)

FLAT A, 2/F, BLK 5, ALTO RESIDENCES,

29 TONG YIN STREET, TSEUNG KWAN O, NT

(Street)

HONG KONG

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
NewGenIvf Group Ltd [ NIVF ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

This Form 3 is being filed after the March 18, 2026 deadline due to delay in issuance of EDGAR access codes following timely submission of the Form ID application on March 11, 2026. The filing is made promptly upon receipt of the access codes.

No securities are beneficially owned.

	/s/ Florianna Ann Chi Wan Ching Chan	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the NewGenIvf Group Ltd (NIVF) Form 3 filing report?

The Form 3 filing reports that director Ching Chan Florianna Ann Chi Wan is an insider of NewGenIvf Group Ltd. It is an initial ownership statement and shows no insider trades or derivative exercises in this disclosure.

Did NewGenIvf Group Ltd (NIVF) insiders buy or sell shares in this Form 3?

No insider share purchases or sales are reported in this Form 3. The transaction summary shows zero buys, zero sells, and no derivative exercises, indicating there were no trading activities disclosed in this filing.

Who is the reporting person in the NewGenIvf Group Ltd (NIVF) Form 3?

The reporting person is Ching Chan Florianna Ann Chi Wan, identified as a director of NewGenIvf Group Ltd. The filing establishes this individual’s status as an insider without reporting any specific equity transactions or derivative positions.

Does the NewGenIvf Group Ltd (NIVF) Form 3 include derivative securities activity?

The Form 3 shows no derivative securities activity for NewGenIvf Group Ltd. The derivative transaction count and exerciseShares are both zero, and the derivative summary is empty, indicating no options, warrants, or similar instruments are reported here.

What does the transaction summary in NewGenIvf Group Ltd (NIVF) Form 3 indicate?

The transaction summary indicates neutral activity, with zero buys, zero sells, and no gifts or restructurings. Net buy-sell direction is described as neutral, highlighting that this filing is purely an initial ownership report without trade disclosures.